STOCK TITAN

Quantinuum: Griffin deemed to hold a 7.3% stake

Ownership percentages use 32,862,895 Quantinuum shares outstanding as of June 5, 2026, while the reported voting and dispositive power is shared.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Quantinuum Inc. is the subject of a joint ownership report covering its Class A common stock by six Citadel entities and Kenneth Griffin. Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC each may be deemed to beneficially own 2,299,997 shares (7.0%). Citadel Securities LLC, Citadel Securities Group LP and Citadel Securities GP LLC each may be deemed to beneficially own 103,430 shares (0.3%). Kenneth Griffin, President and Chief Executive Officer of Citadel GP LLC, may be deemed to beneficially own 2,403,427 shares (7.3%). The reporting persons have shared voting and dispositive power, and zero sole voting and dispositive power. The reported percentages are based on 32,862,895 shares outstanding as of June 5, 2026.

Deemed beneficial ownership — Citadel Advisors LLC 2,299,997 shares Also reported for Citadel Advisors Holdings LP and Citadel GP LLC
Ownership percentage — Citadel Advisors LLC 7.0% Also reported for Citadel Advisors Holdings LP and Citadel GP LLC
Deemed beneficial ownership — Citadel Securities LLC 103,430 shares Also reported for Citadel Securities Group LP and Citadel Securities GP LLC
Ownership percentage — Citadel Securities LLC 0.3% Also reported for Citadel Securities Group LP and Citadel Securities GP LLC
Deemed beneficial ownership — Kenneth Griffin 2,403,427 shares Class A common stock
Ownership percentage — Kenneth Griffin 7.3% Class A common stock
Shares outstanding 32,862,895 shares As of June 5, 2026; basis for the reported percentages
beneficially own regulatory
"may be deemed to beneficially own"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Shared Voting Power regulatory
"Shared Voting Power 2,299,997.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 2,299,997.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many QNT shares may Kenneth Griffin be deemed to own?

Kenneth Griffin may be deemed to beneficially own 2,403,427 shares, or 7.3% of Quantinuum's Class A common stock. The report attributes shared voting and dispositive power over those shares to him.

How many QNT shares may Citadel Advisors be deemed to own?

Citadel Advisors LLC may be deemed to beneficially own 2,299,997 shares, or 7.0% of Quantinuum's Class A common stock. Citadel Advisors Holdings LP and Citadel GP LLC are each also reported with the same deemed beneficial ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





74768A104

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based upon 32,862,895 Shares outstanding as of June 5, 2026 (according to the issuer's prospectus as filed with the Securities and Exchange Commission on June 5, 2026).


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Citadel Advisors LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:10/06/2026
Citadel Advisors Holdings LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:10/06/2026
Citadel GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:10/06/2026
Citadel Securities LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:10/06/2026
Citadel Securities Group LP
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:10/06/2026
Citadel Securities GP LLC
Signature:/s/ Seth Levy
Name/Title:Seth Levy, Authorized Signatory
Date:10/06/2026
Kenneth Griffin
Signature:/s/ Seth Levy
Name/Title:Seth Levy, attorney-in-fact*
Date:10/06/2026

Comments accompanying signature: * Seth Levy is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission, and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Citadel Advisors LLC on Schedule 13G for Allakos Inc. on October 13, 2023.
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement

Keep reading